ClinConnect ClinConnect Logo
Search / Trial NCT05720546

Young Adult Infusion Space Experience Satisfaction Survey

Launched by UNC LINEBERGER COMPREHENSIVE CANCER CENTER · Jan 31, 2023

Trial Information

Current as of August 21, 2025

Recruiting

Keywords

Adolescent Survey

ClinConnect Summary

This clinical trial is looking at how satisfied young adults, ages 18 to 39, are with their experience while receiving cancer treatment in two different infusion spaces at the North Carolina Basnight Cancer Hospital. The study aims to gather feedback from participants through surveys and interviews, focusing on factors like the environment they are treated in and their interactions with mental health staff.

To be eligible for this study, participants must be between 18 and 39 years old, currently receiving treatment for cancer, and able to speak English. They also need to provide written consent to participate. Unfortunately, individuals with certain mental health conditions or those who are currently incarcerated cannot take part in the trial. Participants will share their experiences, which will help improve the care and comfort of young adults undergoing cancer treatment in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Written informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
  • 2. Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
  • 3. Age 18-39 years old at enrollment.
  • 4. Receiving treatment for a cancer diagnosis in Adult Infusion Center or the Adolescent and Young Adult Infusion Center
  • 5. English speaking.
  • Exclusion Criteria:
  • 1. Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent.
  • 2. Current incarceration.

About Unc Lineberger Comprehensive Cancer Center

The UNC Lineberger Comprehensive Cancer Center is a leading research institution dedicated to advancing cancer treatment and prevention through innovative clinical trials and comprehensive patient care. As a National Cancer Institute-designated comprehensive cancer center, it integrates cutting-edge research, interdisciplinary collaboration, and patient-centered approaches to address diverse oncology challenges. With a commitment to translating scientific discoveries into effective therapies, UNC Lineberger strives to improve outcomes for patients while fostering a robust environment for education and training in cancer research.

Locations

Chapel Hill, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Jacob Stein

Principal Investigator

UNC Lineberger Comprehensive Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials